Clinical Trial Update: Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline [Phase 2]

View source ↗

Summary

A Phase 2 trial led by Makerere University is investigating doxycycline to characterize and prevent tuberculosis-associated lung fibrosis and respiratory impair…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis
• Pulmonary Tuberculosis

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Makerere University | Conditions: Tuberculosis, Pulmonary | Phase 2 | Status: RECRUITING